Gp130 receptor ligands as potential therapeutic targets for obesity

被引：101

作者：

Febbraio, Mark A. ^{[1
]}

机构：

[1] Baker Heart Res Inst, Div Diabet & Metab, Cellular & Mol Metab Lab, Melbourne, Vic 8008, Australia

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2007年 / 117卷 / 04期

关键词：

D O I：

10.1172/JCI30453

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Obesity and its related cluster of pathophysiologic conditions including insulin resistance, glucose intolerance, dyslipidemia, and hypertension are recognized as growing threats to world health. It is now estimated that 10% of the world's population is overweight or obese. As a result, new therapeutic options for the treatment of obesity are clearly warranted. Recent research has focused on the role that gp130 receptor ligands may play as potential therapeutic targets in obesity. One cytokine in particular, ciliary neurotrophic factor (CNTF), acts both centrally and peripherally and mimics the biologic actions of the appetite control hormone leptin, but unlike leptin, CNTF appears to be effective in obesity and as such may have therapeutic potential. In addition, CNTF suppresses inflammatory signaling cascades associated with lipid accumulation in liver and skeletal muscle. This review examines the potential role of gp130 receptor ligands as part of a therapeutic strategy to treat obesity.

引用

收藏

页码：841 / 849

页数：9

相关论文

共 113 条

[1] CHOLINERGIC NEURONOTROPIC FACTORS - INTRA-OCULAR DISTRIBUTION OF TROPHIC ACTIVITY FOR CILIARY NEURONS [J].

ADLER, R ;

LANDA, KB ;

MANTHORPE, M ;

VARON, S .

SCIENCE, 1979, 204 (4400) :1434-1436

[2] Overcoming insulin resistance with CNTF [J].

Ahima, RS .

NATURE MEDICINE, 2006, 12 (05) :511-512

[3] Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle [J].

Al-Khalili, Lubna ;

Bouzakri, Karim ;

Glund, Stephan ;

Lonnqvist, Fredrik ;

Koistinen, Heikki A. ;

Krook, Anna .

MOLECULAR ENDOCRINOLOGY, 2006, 20 (12) :3364-3375

[4] AMP-activated protein kinase plays a role in the control of food intake [J].

Andersson, U ;

Filipsson, K ;

Abbott, CR ;

Woods, A ;

Smith, K ;

Bloom, SR ;

Carling, D ;

Small, CJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12005-12008

[5] Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J].

Bastard, JP ;

Jardel, C ;

Bruckert, E ;

Blondy, P ;

Capeau, J ;

Laville, M ;

Vidal, H ;

Hainque, B .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3338-3342

[6] The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors [J].

Baumann, H ;

Morella, KK ;

White, DW ;

Dembski, M ;

Bailon, PS ;

Kim, HK ;

Lai, CF ;

Tartaglia, LA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8374-8378

[7] Leptin signaling in the central nervous system and the periphery [J].

Bjorbæk, C ;

Kahn, BB .

RECENT PROGRESS IN HORMONE RESEARCH, VOL 59: CARDIOVASCULAR ENDOCRINOLOGY & OBESITY, 2004, 59 :305-331

[8] Divergent roles of SHP-2 in ERK activation by leptin receptors [J].

Bjorbæk, C ;

Buchholz, RM ;

Davis, SM ;

Bates, SH ;

Pierroz, DD ;

Gu, H ;

Neel, BG ;

Myers, MG ;

Flier, JS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :4747-4755

[9] Ciliary neurotrophic factor AX15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice [J].

Blüher, S ;

Moschos, S ;

Bullen, J ;

Kokkotou, E ;

Maratos-Flier, E ;

Wiegand, SJ ;

Sleemann, MW ;

Mantzoros, CS .

DIABETES, 2004, 53 (11) :2787-2796

[10] Molecular phylogeny within type I cytokines and their cognate receptors [J].

Boulay, JL ;

O'Shea, JJ ;

Paul, WE .

IMMUNITY, 2003, 19 (02) :159-163

← 1 2 3 4 5 6 7 8 9 10 →